SPRAVATO, First New Depression Medication In 30 Years, Approved by FDA
Cooper Smith ❘
In a historic 14-to-2 vote the FDA has approved Janssen Pharmaceuticals new medication, Spravato, for clinical depression.
Read More ⟶
Get the latest on addiction and recovery.